The European Congress of Clinical Microbiology and Infectious Disease recently highlighted key threats to public health, as well as the latest innovation and research.
Organised by the European Society of Clinical Microbiology and Infectious Disease (ESCMID), the 25th edition of the European Congress of Clinical Microbiology and Infectious Disease (ECCMID) was recently held in Copenhagen, Denmark – bringing together leading microbial experts, companies and scientists from all over the world.
A topic that generated incredible in-depth discussions and one that is at the forefront of ECCMID’s agenda is antimicrobial resistance. Over the last two decades, global communities have gradually acknowledged the importance of tackling this issue – for example, the World Health Organization(WHO) has recently defined antimicrobial resistance as a “major global threat” to public health. As a result of changing political agendas, university discoveries and national news, interest in finding solutions to this problem have increased dramatically.
From clinicians and other specialists attending ECCMID there is a general consensus that it is not the world of big pharma that will provide all the answers to antimicrobial resistance. Prof. Marc Bonten, a specialist for molecular epidemiology of infectious diseases at the UMC in Utrecht, Netherlands, identified the need to look to universities to provide the answer for fighting antimicrobial resistance and commented that it is time to look to academics to instigate groundbreaking discoveries.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
